Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Berk, M.D.
Arcutis Biotherapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dr. Chih-Ho Hong Medical Inc.
Surrey, British Columbia, Canada
- Lynderm Research Inc.
Markham, Ontario, Canada
- Research By Icls
Oakville, Ontario, Canada
- Skin Centre for Dermatology
Peterborough, Ontario, Canada
- the Centre for Dermatology
Richmond Hill, Ontario, Canada
- K. Papp Clinical Research Inc.
Waterloo, Ontario, Canada
- Xlr8 Medical Research Inc.
Windsor, Ontario, Canada
- Mosaic Dermatology
Santa Monica, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Dec 2017
- Primary completion
- 2 May 2018
- Completion
- 2 May 2018
- Last update posted
- 4 Aug 2022
- Registered enrollment
- 91
- Registry id
- NCT03392168
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.